SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000818686-08-000095
Filing Date
2008-06-16
Accepted
2008-06-16 07:15:26
Documents
3
Period of Report
2008-06-16

Document Format Files

Seq Description Document Type Size
1 TEVA'S AZILECT? 1 MG TABLETS MEET END POINTS IN ADAGIO PHASE III TRIAL adagio160608.htm 6-K 64505
3 LOGO image001.jpg GRAPHIC 3735
4 TEVA'S AZILECT? 1 MG TABLETS MEET END POINTS IN ADAGIO PHASE III TRIAL-PRINTER F adagio160608.pdf 6-K 265821
  Complete submission text file 0000818686-08-000095.txt   437710
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-16174 | Film No.: 08899388
SIC: 2834 Pharmaceutical Preparations